Hangzhou Diagens Biotechnology Co., Ltd. (2526)
Market Closed
29 Sep, 08:00 AM
HKEX HKEX Primary 303. 20
HKD -32.2
-9.6005%
38.56B Market Cap
- P/E Ratio
- Div Yield
58,100 Volume
- Eps
335.4 HKD
Previous Close Want to track 2526 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hangzhou Diagens Biotechnology Co., Ltd. (2526) Statistics
Valuation metrics
Market Cap 38.56B
Enterprise value 44.38B
Trailing P/E (ttm) -661.92
Forward P/E -
PEG ratio -
Price/Sales (ttm) 210.33
Price/Book (mrq) 42.59
Enterprise Value/Revenue 207.16
Enterprise Value/EBITDA -348
Overview
Shares outstanding 88.88M
Float 35.9M
Shares short -
% Held by insiders 0.61%
% Held by institutions 0.29%
Average volume (10 days) 93.65K
Average volume (90 days) 61.88K
Price summary
52-Week low 178
52-Week high 765.5
Beta -
50-Day moving average 399.29
200-Day moving average 344.52
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2026
Profitability
Profit margin -0.66%
Operating margin -0.44%
Operational effectiveness
Return on assets -0.31%
Return on equity -0.41%
Income Statement
Revenue (ttm) 214.21M
Revenue per share (ttm) 2.21
Quarterly revenue growth (yoy) 0.21%
Gross profit (ttm) 149.54M
EBITDA -127.52M
Net income to common (ttm) -142.19M
Diluted EPS (ttm) -1.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 764.93M
Total cash per share (mrq) 7.37
Total debt (mrq) 65.07M
Total Debt/Equity (mrq) 7.18
Current ratio (mrq) 7.32%
Book value per share (mrq) 10.19
Cash Flow
Cash flow statement -178.05M
Levered free cash flow (LFCF) -67.14M
2026 © Marketlog. All Rights Reserved.
